

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.10873338 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.10873338 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.47737893 |
| 4 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 4.20009620 |
| 5 | Golgi transport vesicle coating (GO:0048200) | 3.75476171 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 3.75476171 |
| 7 | positive regulation of histone deacetylation (GO:0031065) | 3.70140696 |
| 8 | intestinal absorption (GO:0050892) | 3.69755365 |
| 9 | desmosome organization (GO:0002934) | 3.67816728 |
| 10 | regulation of cholesterol homeostasis (GO:2000188) | 3.66137250 |
| 11 | low-density lipoprotein particle clearance (GO:0034383) | 3.60148012 |
| 12 | hemidesmosome assembly (GO:0031581) | 3.37631595 |
| 13 | activation of Rac GTPase activity (GO:0032863) | 3.33469887 |
| 14 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.31205199 |
| 15 | pentose-phosphate shunt (GO:0006098) | 3.28192498 |
| 16 | regulation of cholesterol storage (GO:0010885) | 3.17779693 |
| 17 | valine metabolic process (GO:0006573) | 3.14732100 |
| 18 | apoptotic cell clearance (GO:0043277) | 3.09662872 |
| 19 | intestinal cholesterol absorption (GO:0030299) | 3.08991104 |
| 20 | mannose metabolic process (GO:0006013) | 3.04381309 |
| 21 | epithelial cell-cell adhesion (GO:0090136) | 3.03605019 |
| 22 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02184306 |
| 23 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.01697187 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 3.00043934 |
| 25 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.99572709 |
| 26 | skin morphogenesis (GO:0043589) | 2.97852482 |
| 27 | NADPH regeneration (GO:0006740) | 2.97433648 |
| 28 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96356612 |
| 29 | cell-substrate junction assembly (GO:0007044) | 2.94980088 |
| 30 | amyloid precursor protein catabolic process (GO:0042987) | 2.92972159 |
| 31 | protein localization to endosome (GO:0036010) | 2.92167820 |
| 32 | positive regulation of nuclease activity (GO:0032075) | 2.92124213 |
| 33 | barbed-end actin filament capping (GO:0051016) | 2.87706286 |
| 34 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.86483205 |
| 35 | proline biosynthetic process (GO:0006561) | 2.86330410 |
| 36 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.85650883 |
| 37 | adherens junction assembly (GO:0034333) | 2.84935206 |
| 38 | tricarboxylic acid metabolic process (GO:0072350) | 2.82814213 |
| 39 | growth hormone receptor signaling pathway (GO:0060396) | 2.81647688 |
| 40 | endothelial cell chemotaxis (GO:0035767) | 2.80797345 |
| 41 | maternal placenta development (GO:0001893) | 2.79373089 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79214001 |
| 43 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.78249096 |
| 44 | cell-substrate adherens junction assembly (GO:0007045) | 2.75658028 |
| 45 | focal adhesion assembly (GO:0048041) | 2.75658028 |
| 46 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.74857135 |
| 47 | semaphorin-plexin signaling pathway (GO:0071526) | 2.74091608 |
| 48 | alpha-linolenic acid metabolic process (GO:0036109) | 2.71847763 |
| 49 | response to laminar fluid shear stress (GO:0034616) | 2.71179604 |
| 50 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.71103448 |
| 51 | 4-hydroxyproline metabolic process (GO:0019471) | 2.70664992 |
| 52 | protein retention in ER lumen (GO:0006621) | 2.70387164 |
| 53 | negative regulation of viral release from host cell (GO:1902187) | 2.70097756 |
| 54 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.69986647 |
| 55 | regulation of early endosome to late endosome transport (GO:2000641) | 2.68501773 |
| 56 | negative regulation of fatty acid transport (GO:2000192) | 2.68279273 |
| 57 | regulation of T cell tolerance induction (GO:0002664) | 2.66382431 |
| 58 | embryonic process involved in female pregnancy (GO:0060136) | 2.66281741 |
| 59 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.66048469 |
| 60 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.65712440 |
| 61 | positive regulation of protein deacetylation (GO:0090312) | 2.65296486 |
| 62 | membrane protein ectodomain proteolysis (GO:0006509) | 2.65257201 |
| 63 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.65015036 |
| 64 | epithelial structure maintenance (GO:0010669) | 2.64955329 |
| 65 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.64245150 |
| 66 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.62050803 |
| 67 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.62026920 |
| 68 | GDP-mannose metabolic process (GO:0019673) | 2.61130262 |
| 69 | regulation of water loss via skin (GO:0033561) | 2.60725833 |
| 70 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.59826298 |
| 71 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.59156119 |
| 72 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59022239 |
| 73 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.58639422 |
| 74 | response to peptidoglycan (GO:0032494) | 2.58565529 |
| 75 | positive regulation of pseudopodium assembly (GO:0031274) | 2.58516264 |
| 76 | regulation of nuclease activity (GO:0032069) | 2.58132435 |
| 77 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.56977935 |
| 78 | regulation of gamma-delta T cell activation (GO:0046643) | 2.55847483 |
| 79 | pinocytosis (GO:0006907) | 2.55148480 |
| 80 | regulation of viral release from host cell (GO:1902186) | 2.54768468 |
| 81 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.54590793 |
| 82 | hypotonic response (GO:0006971) | 2.54579449 |
| 83 | receptor catabolic process (GO:0032801) | 2.52942554 |
| 84 | positive thymic T cell selection (GO:0045059) | 2.52478879 |
| 85 | apoptotic process involved in morphogenesis (GO:0060561) | 2.51962668 |
| 86 | hormone catabolic process (GO:0042447) | 2.51039601 |
| 87 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.50579446 |
| 88 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.50510689 |
| 89 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.48510065 |
| 90 | iron ion import (GO:0097286) | 2.47569138 |
| 91 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.46818761 |
| 92 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.46531085 |
| 93 | negative regulation of cholesterol transport (GO:0032375) | 2.45171181 |
| 94 | negative regulation of sterol transport (GO:0032372) | 2.45171181 |
| 95 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.44642288 |
| 96 | modulation by symbiont of host immune response (GO:0052553) | 2.44308351 |
| 97 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44308351 |
| 98 | modulation by symbiont of host defense response (GO:0052031) | 2.44308351 |
| 99 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44308351 |
| 100 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44308351 |
| 101 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44308351 |
| 102 | flavonoid metabolic process (GO:0009812) | 2.44256163 |
| 103 | regulation of vitamin metabolic process (GO:0030656) | 2.43478321 |
| 104 | glucose 6-phosphate metabolic process (GO:0051156) | 2.42271398 |
| 105 | positive regulation of receptor recycling (GO:0001921) | 2.41453602 |
| 106 | stress fiber assembly (GO:0043149) | 2.40391333 |
| 107 | protein autoprocessing (GO:0016540) | 2.40159661 |
| 108 | O-glycan processing (GO:0016266) | 2.40158678 |
| 109 | glycosphingolipid catabolic process (GO:0046479) | 2.40140448 |
| 110 | modulation by symbiont of host cellular process (GO:0044068) | 2.39591440 |
| 111 | COPII vesicle coating (GO:0048208) | 2.38150247 |
| 112 | L-serine transport (GO:0015825) | 2.37165855 |
| 113 | cellular response to unfolded protein (GO:0034620) | 2.37008130 |
| 114 | negative regulation of lipid transport (GO:0032369) | 2.36319605 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.34993104 |
| 116 | mammary gland epithelial cell differentiation (GO:0060644) | 2.34418614 |
| 117 | white fat cell differentiation (GO:0050872) | 2.34024217 |
| 118 | cellular response to growth hormone stimulus (GO:0071378) | 2.33334980 |
| 119 | amyloid precursor protein metabolic process (GO:0042982) | 2.32729701 |
| 120 | negative regulation of cell size (GO:0045792) | 2.31628792 |
| 121 | regulation of integrin activation (GO:0033623) | 2.31290843 |
| 122 | lipoprotein transport (GO:0042953) | 2.31033235 |
| 123 | regulation of fatty acid oxidation (GO:0046320) | 2.30664002 |
| 124 | cell-cell junction maintenance (GO:0045217) | 2.30565777 |
| 125 | modulation by virus of host morphology or physiology (GO:0019048) | 2.30300536 |
| 126 | sodium ion export (GO:0071436) | 2.29783135 |
| 127 | regulation of defense response to virus by virus (GO:0050690) | 2.29751774 |
| 128 | serine transport (GO:0032329) | 2.28890956 |
| 129 | oxaloacetate metabolic process (GO:0006107) | 2.28359297 |
| 130 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.28169552 |
| 131 | sulfation (GO:0051923) | 2.28082840 |
| 132 | protein-lipid complex assembly (GO:0065005) | 2.27814981 |
| 133 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.27574661 |
| 134 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.27511952 |
| 135 | cellular response to virus (GO:0098586) | 2.27117462 |
| 136 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.26742110 |
| 137 | angiotensin maturation (GO:0002003) | 2.26160226 |
| 138 | basement membrane organization (GO:0071711) | 2.25891883 |
| 139 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.25883262 |
| 140 | trophectodermal cell differentiation (GO:0001829) | 2.25521399 |
| 141 | NADH metabolic process (GO:0006734) | 2.25422038 |
| 142 | positive regulation of tolerance induction (GO:0002645) | 2.25417759 |
| 143 | ER-nucleus signaling pathway (GO:0006984) | 2.25005597 |
| 144 | diacylglycerol metabolic process (GO:0046339) | 2.24843340 |
| 145 | response to food (GO:0032094) | 2.23225245 |
| 146 | actin filament bundle assembly (GO:0051017) | 2.23111901 |
| 147 | actin filament bundle organization (GO:0061572) | 2.23111901 |
| 148 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.22791553 |
| 149 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.22558334 |
| 150 | glucose catabolic process (GO:0006007) | 2.22410945 |
| 151 | positive regulation of p38MAPK cascade (GO:1900745) | 2.21692764 |
| 152 | sexual reproduction (GO:0019953) | 2.21682514 |
| 153 | regulation of extracellular matrix disassembly (GO:0010715) | 2.21449601 |
| 154 | positive regulation of fatty acid oxidation (GO:0046321) | 2.20831381 |
| 155 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.20794983 |
| 156 | fatty acid beta-oxidation (GO:0006635) | 2.20766923 |
| 157 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.20721437 |
| 158 | lysine metabolic process (GO:0006553) | 2.20217759 |
| 159 | lysine catabolic process (GO:0006554) | 2.20217759 |
| 160 | vesicle coating (GO:0006901) | 2.19214103 |
| 161 | adhesion of symbiont to host (GO:0044406) | 2.18768950 |
| 162 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.18564830 |
| 163 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.18454453 |
| 164 | regulation of triglyceride catabolic process (GO:0010896) | 2.18452660 |
| 165 | positive regulation of lipid storage (GO:0010884) | 2.18162842 |
| 166 | cellular response to topologically incorrect protein (GO:0035967) | 2.17721123 |
| 167 | negative regulation of innate immune response (GO:0045824) | 2.16898805 |
| 168 | defense response to fungus (GO:0050832) | 2.15893656 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.41874594 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.17103962 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.72030368 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61442632 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.60604295 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.50536116 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41449505 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.38441120 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36545798 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.23113722 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.11958721 |
| 12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.10741133 |
| 13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.06733193 |
| 14 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03418321 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.03131872 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.01845936 |
| 17 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.00338160 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97583787 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.95861354 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89529240 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.88236453 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.86235626 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83765738 |
| 24 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.83343122 |
| 25 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.76695838 |
| 26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76309241 |
| 27 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.76195734 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74851113 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 1.72354541 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71556349 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71500249 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.66570368 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.64045006 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62507569 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.61861724 |
| 36 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60266214 |
| 37 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.58769350 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58655867 |
| 39 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58557893 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55554900 |
| 41 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.54795004 |
| 42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53370442 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53219423 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.51206765 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51095021 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48503577 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48090103 |
| 48 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.46800975 |
| 49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.44496215 |
| 50 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42999599 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42625413 |
| 52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.42583447 |
| 53 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.41435749 |
| 54 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.40057656 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.38982343 |
| 56 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.38454647 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37944804 |
| 58 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37510402 |
| 59 | GATA1_19941826_ChIP-Seq_K562_Human | 1.36178210 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.35508484 |
| 61 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31435259 |
| 62 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.30720247 |
| 63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30559251 |
| 64 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.30327981 |
| 65 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30156722 |
| 66 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.29366146 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28571426 |
| 68 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28237629 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27499784 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27332560 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25579268 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25082789 |
| 73 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.23659622 |
| 74 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.21788187 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.21575154 |
| 76 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.21282239 |
| 77 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20941097 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20372746 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 1.19797900 |
| 80 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.19724002 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19492106 |
| 82 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.19147461 |
| 83 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18832142 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17880404 |
| 85 | * P68_20966046_ChIP-Seq_HELA_Human | 1.17735889 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.17482236 |
| 87 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17467291 |
| 88 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16578796 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15157932 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.15148501 |
| 91 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.14626888 |
| 92 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13719606 |
| 93 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.13273608 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13207296 |
| 95 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12305307 |
| 96 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11944372 |
| 97 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.11834882 |
| 98 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09742120 |
| 99 | MYB_26560356_Chip-Seq_TH2_Human | 1.09661156 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.09087447 |
| 101 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.08861837 |
| 102 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08445500 |
| 103 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.08431945 |
| 104 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07419312 |
| 105 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.07064272 |
| 106 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06803095 |
| 107 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.06790507 |
| 108 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06742014 |
| 109 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.06654444 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06541520 |
| 111 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.06157524 |
| 112 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.06157524 |
| 113 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06014762 |
| 114 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.05907348 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05455021 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05446660 |
| 117 | MAF_26560356_Chip-Seq_TH2_Human | 1.05244535 |
| 118 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04486875 |
| 119 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03579267 |
| 120 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02718003 |
| 121 | MYB_26560356_Chip-Seq_TH1_Human | 1.01258167 |
| 122 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00795581 |
| 123 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.00554202 |
| 124 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.00276291 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.00125973 |
| 126 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00072239 |
| 127 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98348098 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.96115456 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96073479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 3.50733648 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.40351580 |
| 3 | MP0003300_gastrointestinal_ulcer | 3.20451647 |
| 4 | MP0005451_abnormal_body_composition | 3.17685273 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 2.88004533 |
| 6 | MP0009840_abnormal_foam_cell | 2.82919619 |
| 7 | MP0004858_abnormal_nervous_system | 2.63297229 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 2.51421279 |
| 9 | MP0003252_abnormal_bile_duct | 2.34336079 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.30845928 |
| 11 | MP0002796_impaired_skin_barrier | 2.28376683 |
| 12 | MP0001873_stomach_inflammation | 2.22118497 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.19922260 |
| 14 | MP0003303_peritoneal_inflammation | 2.09889010 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.05693856 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 1.94413436 |
| 17 | MP0003866_abnormal_defecation | 1.92386418 |
| 18 | MP0010352_gastrointestinal_tract_polyps | 1.90381696 |
| 19 | MP0005409_darkened_coat_color | 1.88024542 |
| 20 | MP0010155_abnormal_intestine_physiology | 1.86499100 |
| 21 | MP0008260_abnormal_autophagy | 1.83461832 |
| 22 | MP0000685_abnormal_immune_system | 1.83453298 |
| 23 | MP0006054_spinal_hemorrhage | 1.83380405 |
| 24 | MP0005365_abnormal_bile_salt | 1.76939797 |
| 25 | MP0010329_abnormal_lipoprotein_level | 1.76579428 |
| 26 | MP0008961_abnormal_basal_metabolism | 1.74900685 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.71263075 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.70022776 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.66919508 |
| 30 | MP0005085_abnormal_gallbladder_physiolo | 1.64457345 |
| 31 | MP0003283_abnormal_digestive_organ | 1.58564735 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.57656687 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.54761057 |
| 34 | MP0001849_ear_inflammation | 1.54705139 |
| 35 | MP0005501_abnormal_skin_physiology | 1.53270583 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.53129806 |
| 37 | MP0003566_abnormal_cell_adhesion | 1.46276499 |
| 38 | MP0000609_abnormal_liver_physiology | 1.45652033 |
| 39 | MP0004185_abnormal_adipocyte_glucose | 1.45325092 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.44535126 |
| 41 | MP0004233_abnormal_muscle_weight | 1.44137224 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.41343480 |
| 43 | MP0003436_decreased_susceptibility_to | 1.40248404 |
| 44 | MP0004130_abnormal_muscle_cell | 1.39887091 |
| 45 | MP0005023_abnormal_wound_healing | 1.38608818 |
| 46 | MP0009278_abnormal_bone_marrow | 1.38487922 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.37828864 |
| 48 | MP0004947_skin_inflammation | 1.36663412 |
| 49 | MP0005666_abnormal_adipose_tissue | 1.33148911 |
| 50 | MP0003724_increased_susceptibility_to | 1.32831747 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.31235963 |
| 52 | MP0002098_abnormal_vibrissa_morphology | 1.30577816 |
| 53 | MP0001663_abnormal_digestive_system | 1.30375909 |
| 54 | MP0005670_abnormal_white_adipose | 1.28950297 |
| 55 | MP0001790_abnormal_immune_system | 1.25486059 |
| 56 | MP0005387_immune_system_phenotype | 1.25486059 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.25158924 |
| 58 | MP0005257_abnormal_intraocular_pressure | 1.24882562 |
| 59 | MP0000477_abnormal_intestine_morphology | 1.24545479 |
| 60 | MP0004782_abnormal_surfactant_physiolog | 1.24232173 |
| 61 | MP0001216_abnormal_epidermal_layer | 1.23725883 |
| 62 | MP0001958_emphysema | 1.20534267 |
| 63 | MP0000490_abnormal_crypts_of | 1.18449195 |
| 64 | MP0002118_abnormal_lipid_homeostasis | 1.17456913 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 1.16161051 |
| 66 | MP0002896_abnormal_bone_mineralization | 1.15654259 |
| 67 | MP0005083_abnormal_biliary_tract | 1.15251225 |
| 68 | MP0005076_abnormal_cell_differentiation | 1.15052439 |
| 69 | MP0005375_adipose_tissue_phenotype | 1.14549031 |
| 70 | MP0003075_altered_response_to | 1.13555782 |
| 71 | MP0005381_digestive/alimentary_phenotyp | 1.09286263 |
| 72 | MP0000627_abnormal_mammary_gland | 1.08271595 |
| 73 | MP0001835_abnormal_antigen_presentation | 1.07745564 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.06958951 |
| 75 | MP0005025_abnormal_response_to | 1.06360621 |
| 76 | MP0000604_amyloidosis | 1.06140281 |
| 77 | MP0001881_abnormal_mammary_gland | 1.06133850 |
| 78 | MP0002909_abnormal_adrenal_gland | 1.03819070 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.03403696 |
| 80 | MP0002254_reproductive_system_inflammat | 1.02663467 |
| 81 | MP0001845_abnormal_inflammatory_respons | 1.02128516 |
| 82 | MP0002166_altered_tumor_susceptibility | 1.01748610 |
| 83 | MP0002006_tumorigenesis | 1.00251839 |
| 84 | MP0001800_abnormal_humoral_immune | 0.99733988 |
| 85 | MP0004510_myositis | 0.97743476 |
| 86 | MP0003045_fibrosis | 0.97044595 |
| 87 | MP0009333_abnormal_splenocyte_physiolog | 0.96958485 |
| 88 | MP0000462_abnormal_digestive_system | 0.96764128 |
| 89 | MP0002452_abnormal_antigen_presenting | 0.96145382 |
| 90 | MP0003091_abnormal_cell_migration | 0.94917406 |
| 91 | MP0001533_abnormal_skeleton_physiology | 0.94837835 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.94454581 |
| 93 | MP0005275_abnormal_skin_tensile | 0.94017738 |
| 94 | MP0000003_abnormal_adipose_tissue | 0.92584094 |
| 95 | MP0000537_abnormal_urethra_morphology | 0.92211066 |
| 96 | MP0003448_altered_tumor_morphology | 0.91187963 |
| 97 | MP0002060_abnormal_skin_morphology | 0.90461067 |
| 98 | MP0005310_abnormal_salivary_gland | 0.90378736 |
| 99 | MP0002089_abnormal_postnatal_growth/wei | 0.89776242 |
| 100 | MP0004043_abnormal_pH_regulation | 0.89664806 |
| 101 | MP0006082_CNS_inflammation | 0.89443325 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.89443289 |
| 103 | MP0002009_preneoplasia | 0.89443211 |
| 104 | MP0005166_decreased_susceptibility_to | 0.89413555 |
| 105 | MP0009931_abnormal_skin_appearance | 0.88665545 |
| 106 | MP0003329_amyloid_beta_deposits | 0.88361544 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.88280287 |
| 108 | MP0000598_abnormal_liver_morphology | 0.88116107 |
| 109 | MP0008469_abnormal_protein_level | 0.87525156 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.87417924 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.87151347 |
| 112 | MP0001664_abnormal_digestion | 0.86573030 |
| 113 | MP0002405_respiratory_system_inflammati | 0.86315219 |
| 114 | MP0004272_abnormal_basement_membrane | 0.86135434 |
| 115 | MP0003868_abnormal_feces_composition | 0.85897292 |
| 116 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85771144 |
| 117 | MP0005332_abnormal_amino_acid | 0.85217064 |
| 118 | MP0002419_abnormal_innate_immunity | 0.85024973 |
| 119 | MP0000858_altered_metastatic_potential | 0.84894227 |
| 120 | MP0005000_abnormal_immune_tolerance | 0.84758237 |
| 121 | MP0001819_abnormal_immune_cell | 0.84274572 |
| 122 | MP0002420_abnormal_adaptive_immunity | 0.83555829 |
| 123 | MP0002723_abnormal_immune_serum | 0.82744552 |
| 124 | MP0000467_abnormal_esophagus_morphology | 0.81505983 |
| 125 | MP0003279_aneurysm | 0.81171646 |
| 126 | MP0000733_abnormal_muscle_development | 0.79162819 |
| 127 | MP0000377_abnormal_hair_follicle | 0.77326225 |
| 128 | MP0009785_altered_susceptibility_to | 0.76935185 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.76343983 |
| 130 | MP0005621_abnormal_cell_physiology | 0.75474520 |
| 131 | MP0005623_abnormal_meninges_morphology | 0.74924513 |
| 132 | MP0002148_abnormal_hypersensitivity_rea | 0.73493523 |
| 133 | MP0002396_abnormal_hematopoietic_system | 0.72393926 |
| 134 | MP0003795_abnormal_bone_structure | 0.70706511 |
| 135 | MP0003763_abnormal_thymus_physiology | 0.69866268 |
| 136 | MP0005390_skeleton_phenotype | 0.69029997 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.68995273 |
| 138 | MP0000681_abnormal_thyroid_gland | 0.68330622 |
| 139 | MP0003828_pulmonary_edema | 0.67970039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dysostosis multiplex (HP:0000943) | 3.60327586 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.59488730 |
| 3 | Mucopolysacchariduria (HP:0008155) | 3.52058971 |
| 4 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.52058971 |
| 5 | Abnormality of the nasal mucosa (HP:0000433) | 3.46560878 |
| 6 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.22695944 |
| 7 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.22695944 |
| 8 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.22695944 |
| 9 | Nasal polyposis (HP:0100582) | 3.18850460 |
| 10 | Hyperacusis (HP:0010780) | 3.17423349 |
| 11 | Pustule (HP:0200039) | 3.14380351 |
| 12 | Broad face (HP:0000283) | 3.06488291 |
| 13 | Vertebral compression fractures (HP:0002953) | 2.89241612 |
| 14 | Aortic aneurysm (HP:0004942) | 2.88144021 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 2.87395347 |
| 16 | Protrusio acetabuli (HP:0003179) | 2.69310940 |
| 17 | Ileus (HP:0002595) | 2.66746456 |
| 18 | Cervical subluxation (HP:0003308) | 2.65902638 |
| 19 | Short nail (HP:0001799) | 2.65219370 |
| 20 | Increased connective tissue (HP:0009025) | 2.65022162 |
| 21 | Gastrointestinal inflammation (HP:0004386) | 2.64066624 |
| 22 | Polycythemia (HP:0001901) | 2.61113145 |
| 23 | Autoimmune thrombocytopenia (HP:0001973) | 2.56939060 |
| 24 | Distal lower limb amyotrophy (HP:0008944) | 2.55384682 |
| 25 | Chronic otitis media (HP:0000389) | 2.54569520 |
| 26 | Sparse lateral eyebrow (HP:0005338) | 2.52538768 |
| 27 | * Flat acetabular roof (HP:0003180) | 2.52505593 |
| 28 | Inflammation of the large intestine (HP:0002037) | 2.50471373 |
| 29 | Right ventricular cardiomyopathy (HP:0011663) | 2.49914969 |
| 30 | Aneurysm (HP:0002617) | 2.47683808 |
| 31 | Achilles tendon contracture (HP:0001771) | 2.46230227 |
| 32 | Colitis (HP:0002583) | 2.42816053 |
| 33 | Hyperparathyroidism (HP:0000843) | 2.42025121 |
| 34 | Hemorrhage of the eye (HP:0011885) | 2.40378637 |
| 35 | Aortic dissection (HP:0002647) | 2.36932138 |
| 36 | Polygenic inheritance (HP:0010982) | 2.34511244 |
| 37 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.32769131 |
| 38 | Osteolytic defects of the hand bones (HP:0009699) | 2.32769131 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.30848333 |
| 40 | Peritonitis (HP:0002586) | 2.28301380 |
| 41 | Hand muscle atrophy (HP:0009130) | 2.27441048 |
| 42 | Distal lower limb muscle weakness (HP:0009053) | 2.27420683 |
| 43 | Deep venous thrombosis (HP:0002625) | 2.26984945 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.26918883 |
| 45 | Upper limb amyotrophy (HP:0009129) | 2.25791190 |
| 46 | Distal upper limb amyotrophy (HP:0007149) | 2.25791190 |
| 47 | Xanthomatosis (HP:0000991) | 2.25406204 |
| 48 | Bone pain (HP:0002653) | 2.25392887 |
| 49 | Interstitial pulmonary disease (HP:0006530) | 2.24616360 |
| 50 | Increased cerebral lipofuscin (HP:0011813) | 2.22018036 |
| 51 | Asymmetric septal hypertrophy (HP:0001670) | 2.21875198 |
| 52 | Thin bony cortex (HP:0002753) | 2.17178528 |
| 53 | Malnutrition (HP:0004395) | 2.16109162 |
| 54 | Axonal loss (HP:0003447) | 2.14124476 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.13908338 |
| 56 | Abdominal distention (HP:0003270) | 2.11845783 |
| 57 | Late onset (HP:0003584) | 2.11383560 |
| 58 | Dilatation of the ascending aorta (HP:0005111) | 2.09988558 |
| 59 | Abnormality of macrophages (HP:0004311) | 2.09111295 |
| 60 | Mitral valve prolapse (HP:0001634) | 2.08037842 |
| 61 | Ketoacidosis (HP:0001993) | 2.07818867 |
| 62 | Asymmetry of the thorax (HP:0001555) | 2.06871061 |
| 63 | Spinal cord compression (HP:0002176) | 2.06801259 |
| 64 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.05983324 |
| 65 | Gastrointestinal dysmotility (HP:0002579) | 2.04703419 |
| 66 | Loss of speech (HP:0002371) | 2.04161805 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.03072439 |
| 68 | Shallow orbits (HP:0000586) | 2.02121024 |
| 69 | Hematochezia (HP:0002573) | 2.00942084 |
| 70 | Long palpebral fissure (HP:0000637) | 2.00875534 |
| 71 | * Blue sclerae (HP:0000592) | 2.00276115 |
| 72 | Hydroxyprolinuria (HP:0003080) | 1.99705004 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 1.99705004 |
| 74 | Bladder diverticulum (HP:0000015) | 1.99677192 |
| 75 | Recurrent viral infections (HP:0004429) | 1.97560514 |
| 76 | Complement deficiency (HP:0004431) | 1.96427906 |
| 77 | Abnormality of glycolipid metabolism (HP:0010969) | 1.96296762 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.96296762 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.96296762 |
| 80 | Long toe (HP:0010511) | 1.95975125 |
| 81 | Arterial tortuosity (HP:0005116) | 1.94375796 |
| 82 | Abnormal vertebral ossification (HP:0100569) | 1.94011701 |
| 83 | Cardiomegaly (HP:0001640) | 1.93893236 |
| 84 | Abnormal platelet function (HP:0011869) | 1.93271032 |
| 85 | Impaired platelet aggregation (HP:0003540) | 1.93271032 |
| 86 | Hypoglycemic coma (HP:0001325) | 1.92376375 |
| 87 | Difficulty climbing stairs (HP:0003551) | 1.92362079 |
| 88 | Elfin facies (HP:0004428) | 1.92071567 |
| 89 | Eczematoid dermatitis (HP:0000976) | 1.91994558 |
| 90 | * Broad metatarsal (HP:0001783) | 1.90829778 |
| 91 | Fatigue (HP:0012378) | 1.89865451 |
| 92 | Pili torti (HP:0003777) | 1.88385875 |
| 93 | Premature rupture of membranes (HP:0001788) | 1.88144025 |
| 94 | Insomnia (HP:0100785) | 1.86368818 |
| 95 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85860313 |
| 96 | * Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.85628663 |
| 97 | Ulnar bowing (HP:0003031) | 1.84009575 |
| 98 | Fragile skin (HP:0001030) | 1.83965616 |
| 99 | Atrophic scars (HP:0001075) | 1.83825674 |
| 100 | Ankle contracture (HP:0006466) | 1.83575410 |
| 101 | Abnormality of complement system (HP:0005339) | 1.83391426 |
| 102 | Abnormality of T cell physiology (HP:0011840) | 1.83125910 |
| 103 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.82402266 |
| 104 | Recurrent fungal infections (HP:0002841) | 1.81997927 |
| 105 | Ketosis (HP:0001946) | 1.81620126 |
| 106 | Esophageal varix (HP:0002040) | 1.81301129 |
| 107 | Increased IgE level (HP:0003212) | 1.80354553 |
| 108 | Cupped ribs (HP:0000887) | 1.80124067 |
| 109 | Abnormality of the gastric mucosa (HP:0004295) | 1.79317869 |
| 110 | Vascular tortuosity (HP:0004948) | 1.78821436 |
| 111 | Wormian bones (HP:0002645) | 1.78416648 |
| 112 | Mesangial abnormality (HP:0001966) | 1.78288450 |
| 113 | Gingivitis (HP:0000230) | 1.77832039 |
| 114 | Cerebral inclusion bodies (HP:0100314) | 1.77550693 |
| 115 | * Severe short stature (HP:0003510) | 1.77343091 |
| 116 | Advanced eruption of teeth (HP:0006288) | 1.76745933 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 1.74345598 |
| 118 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.73604374 |
| 119 | Abnormality of the thoracic spine (HP:0100711) | 1.73027454 |
| 120 | Bowed forearm bones (HP:0003956) | 1.72932662 |
| 121 | Bowing of the arm (HP:0006488) | 1.72932662 |
| 122 | Overriding aorta (HP:0002623) | 1.71927921 |
| 123 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.71259267 |
| 124 | Disproportionate tall stature (HP:0001519) | 1.70682451 |
| 125 | Ankyloglossia (HP:0010296) | 1.70615417 |
| 126 | Cellulitis (HP:0100658) | 1.70581144 |
| 127 | Myocardial infarction (HP:0001658) | 1.70096582 |
| 128 | Insidious onset (HP:0003587) | 1.70086317 |
| 129 | Termporal pattern (HP:0011008) | 1.70086317 |
| 130 | Recurrent abscess formation (HP:0002722) | 1.68175841 |
| 131 | Elevated alkaline phosphatase (HP:0003155) | 1.67775748 |
| 132 | Radial bowing (HP:0002986) | 1.67392574 |
| 133 | Trismus (HP:0000211) | 1.67002813 |
| 134 | Syringomyelia (HP:0003396) | 1.66986296 |
| 135 | Spinal cord lesions (HP:0100561) | 1.66986296 |
| 136 | Hypercortisolism (HP:0001578) | 1.66212803 |
| 137 | Intrahepatic cholestasis (HP:0001406) | 1.65854230 |
| 138 | Petechiae (HP:0000967) | 1.65493798 |
| 139 | Persistence of primary teeth (HP:0006335) | 1.65429605 |
| 140 | J-shaped sella turcica (HP:0002680) | 1.65387242 |
| 141 | Abnormality of the Achilles tendon (HP:0005109) | 1.65243100 |
| 142 | Growth hormone excess (HP:0000845) | 1.64677391 |
| 143 | Ectopia lentis (HP:0001083) | 1.64473767 |
| 144 | Micronodular cirrhosis (HP:0001413) | 1.64431381 |
| 145 | Ovoid vertebral bodies (HP:0003300) | 1.63806823 |
| 146 | Biconcave vertebral bodies (HP:0004586) | 1.62858243 |
| 147 | Spinal rigidity (HP:0003306) | 1.61900827 |
| 148 | Amyloidosis (HP:0011034) | 1.60877268 |
| 149 | Mitral regurgitation (HP:0001653) | 1.60041363 |
| 150 | Obstructive sleep apnea (HP:0002870) | 1.57998760 |
| 151 | Multiple lipomas (HP:0001012) | 1.57739026 |
| 152 | Curly hair (HP:0002212) | 1.57284515 |
| 153 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.56995853 |
| 154 | Bulbar palsy (HP:0001283) | 1.56798299 |
| 155 | Abnormality of oral frenula (HP:0000190) | 1.56701854 |
| 156 | Germ cell neoplasia (HP:0100728) | 1.55600228 |
| 157 | Alopecia of scalp (HP:0002293) | 1.55350014 |
| 158 | Pathologic fracture (HP:0002756) | 1.54087079 |
| 159 | Metaphyseal cupping (HP:0003021) | 1.53338445 |
| 160 | Tibial bowing (HP:0002982) | 1.52758617 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.49260511 |
| 2 | ERN1 | 4.06844253 |
| 3 | EEF2K | 3.00737924 |
| 4 | PKN2 | 2.99242157 |
| 5 | SMG1 | 2.98320483 |
| 6 | MAP3K10 | 2.96924887 |
| 7 | IRAK3 | 2.65827806 |
| 8 | MAP4K1 | 2.26127904 |
| 9 | PRPF4B | 2.25379527 |
| 10 | TGFBR2 | 2.18609686 |
| 11 | PTK6 | 2.17548074 |
| 12 | RIPK1 | 2.12804780 |
| 13 | LRRK2 | 2.00205394 |
| 14 | KSR2 | 1.78492643 |
| 15 | EPHB1 | 1.75845238 |
| 16 | GRK6 | 1.75096904 |
| 17 | FGFR4 | 1.70759489 |
| 18 | LMTK2 | 1.68642671 |
| 19 | TYK2 | 1.65521278 |
| 20 | SIK1 | 1.54274876 |
| 21 | MAP2K2 | 1.53881197 |
| 22 | TTN | 1.37326300 |
| 23 | SCYL2 | 1.33719488 |
| 24 | TAOK2 | 1.29055085 |
| 25 | PDGFRA | 1.26888913 |
| 26 | TBK1 | 1.24600283 |
| 27 | STK10 | 1.24370921 |
| 28 | MST1R | 1.23756754 |
| 29 | TAOK1 | 1.21773943 |
| 30 | CAMK1D | 1.20530146 |
| 31 | RIPK4 | 1.17230746 |
| 32 | PRKG2 | 1.16276780 |
| 33 | TESK1 | 1.13615222 |
| 34 | JAK1 | 1.13274151 |
| 35 | IRAK4 | 1.12771534 |
| 36 | ZAP70 | 1.11435111 |
| 37 | DYRK1B | 1.09828542 |
| 38 | ITK | 1.07754356 |
| 39 | MAP3K9 | 1.04306769 |
| 40 | CDC42BPA | 1.03554501 |
| 41 | PAK4 | 1.01944941 |
| 42 | ICK | 1.01721270 |
| 43 | BMX | 1.01112918 |
| 44 | PTK2 | 1.00586170 |
| 45 | MAP3K7 | 0.97738300 |
| 46 | FLT3 | 0.97592871 |
| 47 | KDR | 0.97095947 |
| 48 | MAP3K2 | 0.95788091 |
| 49 | TAOK3 | 0.94816173 |
| 50 | MARK2 | 0.93473613 |
| 51 | PAK2 | 0.92831477 |
| 52 | JAK3 | 0.92642602 |
| 53 | MAP3K8 | 0.90076986 |
| 54 | BCKDK | 0.87977861 |
| 55 | JAK2 | 0.87875432 |
| 56 | ARAF | 0.86911009 |
| 57 | PRKD3 | 0.86106819 |
| 58 | CAMK1G | 0.85993816 |
| 59 | CSK | 0.85766598 |
| 60 | BTK | 0.85258883 |
| 61 | MAP3K1 | 0.83015046 |
| 62 | HIPK2 | 0.82169822 |
| 63 | MAP3K13 | 0.82068646 |
| 64 | MAP3K14 | 0.79455185 |
| 65 | RET | 0.79114818 |
| 66 | DDR2 | 0.78732175 |
| 67 | RPS6KA2 | 0.78172341 |
| 68 | HCK | 0.77818562 |
| 69 | CAMKK1 | 0.75654899 |
| 70 | IRAK2 | 0.75288347 |
| 71 | PRKCH | 0.74336119 |
| 72 | MTOR | 0.73988887 |
| 73 | CDK12 | 0.73507624 |
| 74 | PDGFRB | 0.73435542 |
| 75 | MET | 0.73313601 |
| 76 | KIT | 0.73089642 |
| 77 | MAP2K1 | 0.72407395 |
| 78 | BLK | 0.72229950 |
| 79 | MAPKAPK3 | 0.71941097 |
| 80 | TNK2 | 0.70720611 |
| 81 | ALK | 0.70554215 |
| 82 | TGFBR1 | 0.70214348 |
| 83 | MAP3K11 | 0.69439460 |
| 84 | CSF1R | 0.68752933 |
| 85 | TESK2 | 0.68232155 |
| 86 | MATK | 0.67855167 |
| 87 | SIK3 | 0.67093931 |
| 88 | PRKD2 | 0.65698710 |
| 89 | PAK3 | 0.65211863 |
| 90 | CDK7 | 0.64591452 |
| 91 | NTRK1 | 0.64121659 |
| 92 | LATS2 | 0.63354837 |
| 93 | TYRO3 | 0.61945562 |
| 94 | FER | 0.61726206 |
| 95 | RPS6KB2 | 0.61679350 |
| 96 | STK38 | 0.60739771 |
| 97 | NME2 | 0.59132569 |
| 98 | RAF1 | 0.58839560 |
| 99 | PRKCI | 0.58177008 |
| 100 | RPS6KC1 | 0.57091253 |
| 101 | RPS6KL1 | 0.57091253 |
| 102 | MAPK11 | 0.55914252 |
| 103 | DMPK | 0.55253802 |
| 104 | RPS6KA4 | 0.54560797 |
| 105 | EPHB2 | 0.53901780 |
| 106 | MAP3K6 | 0.53458271 |
| 107 | PRKD1 | 0.53286916 |
| 108 | MAP2K3 | 0.53060603 |
| 109 | PDPK1 | 0.52649954 |
| 110 | MAPK15 | 0.49944802 |
| 111 | MAP3K3 | 0.49806729 |
| 112 | PAK6 | 0.49646518 |
| 113 | PRKAA2 | 0.48495734 |
| 114 | TIE1 | 0.48459812 |
| 115 | PASK | 0.47754035 |
| 116 | ILK | 0.46178837 |
| 117 | CDK6 | 0.45779612 |
| 118 | PDK1 | 0.45571147 |
| 119 | PIM2 | 0.44619360 |
| 120 | MST4 | 0.44409056 |
| 121 | MAPKAPK2 | 0.43899319 |
| 122 | SYK | 0.41689629 |
| 123 | EPHA2 | 0.39708249 |
| 124 | CDK4 | 0.38144307 |
| 125 | BRAF | 0.35908086 |
| 126 | CHUK | 0.35488119 |
| 127 | YES1 | 0.35465406 |
| 128 | RPS6KA6 | 0.34988160 |
| 129 | EIF2AK1 | 0.34136126 |
| 130 | FGR | 0.34129562 |
| 131 | IRAK1 | 0.33665773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.31298782 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.24922904 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.03869154 |
| 4 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.01854865 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.93019587 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.77476652 |
| 7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.66324994 |
| 8 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61735081 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 1.61028499 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.60695006 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58731057 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52556710 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52541426 |
| 14 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.50195347 |
| 15 | Hepatitis C_Homo sapiens_hsa05160 | 1.47313682 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.46413796 |
| 17 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.46236166 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.36139000 |
| 19 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.30041935 |
| 20 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.29542161 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29081859 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28765623 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23447729 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.22848939 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22592476 |
| 26 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.21548261 |
| 27 | Bladder cancer_Homo sapiens_hsa05219 | 1.20830209 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.19759517 |
| 29 | Insulin resistance_Homo sapiens_hsa04931 | 1.18693590 |
| 30 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.15659033 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13197137 |
| 32 | Prostate cancer_Homo sapiens_hsa05215 | 1.12442679 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12249751 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11807327 |
| 35 | Influenza A_Homo sapiens_hsa05164 | 1.10693680 |
| 36 | Prion diseases_Homo sapiens_hsa05020 | 1.10070022 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09552032 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.08631749 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.08496670 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08454311 |
| 41 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.08225144 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.08190420 |
| 43 | Hepatitis B_Homo sapiens_hsa05161 | 1.06896706 |
| 44 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.04107271 |
| 45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00170589 |
| 46 | Endocytosis_Homo sapiens_hsa04144 | 0.99841246 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 0.99318575 |
| 48 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98388161 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97138054 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.96802102 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96695166 |
| 52 | Histidine metabolism_Homo sapiens_hsa00340 | 0.96509399 |
| 53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94759760 |
| 54 | Adherens junction_Homo sapiens_hsa04520 | 0.94703865 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92952861 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.92763195 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.92171103 |
| 58 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91610742 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.90419233 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.90381301 |
| 61 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90049779 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.88496307 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.87606696 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.86865867 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85654859 |
| 66 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.84322831 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83493091 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.83363885 |
| 69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81580711 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81385883 |
| 71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.80843640 |
| 72 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.80820452 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80737719 |
| 74 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.80620990 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80488622 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.77496935 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76456685 |
| 78 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75674222 |
| 79 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.75351910 |
| 80 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.75142376 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74598242 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.74472546 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.74067365 |
| 84 | Amoebiasis_Homo sapiens_hsa05146 | 0.73634421 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73414631 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72351481 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.72206595 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.71776053 |
| 89 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71761380 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71695705 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71671612 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.70622475 |
| 93 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.69663157 |
| 94 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68684304 |
| 95 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68529766 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.68270968 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67740840 |
| 98 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.67711092 |
| 99 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.67341134 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.66965111 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66525796 |
| 102 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.65743759 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.65738852 |
| 104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65567846 |
| 105 | Legionellosis_Homo sapiens_hsa05134 | 0.65062665 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64887133 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64265701 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63817861 |
| 109 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63572658 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63418549 |
| 111 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62540188 |
| 112 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62442021 |
| 113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62353339 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62103082 |
| 115 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.61952346 |
| 116 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61666206 |
| 117 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61255988 |
| 118 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61126934 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60960854 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60615094 |
| 121 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60348893 |
| 122 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.60281934 |
| 123 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59440677 |
| 124 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58429370 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58377297 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58060925 |
| 127 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57934897 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.57368027 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56965635 |
| 130 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56642031 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56547958 |
| 132 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56157649 |
| 133 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55877357 |
| 134 | Colorectal cancer_Homo sapiens_hsa05210 | 0.55222868 |
| 135 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54190363 |
| 136 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54085871 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.53979647 |
| 138 | Phagosome_Homo sapiens_hsa04145 | 0.53882591 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53561424 |
| 140 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.53422424 |
| 141 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53410731 |
| 142 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52915103 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52022437 |
| 144 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.51823506 |
| 145 | Tuberculosis_Homo sapiens_hsa05152 | 0.49535388 |
| 146 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.49010105 |

